Back to Search Start Over

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.

Details

Language :
English
ISSN :
0732183X
Volume :
33
Issue :
34
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
111081063
Full Text :
https://doi.org/10.1200/JCO.2015.62.3397